Stem Cell Transplantation for Newly Diagnosed M/M
IMS 2022 ATLAS: A Phase 3 Randomized Trial of Carfilzomib, Lenalidomide, and Dexamethasone vs. Lenalidomide Alone After ASCT for MM
Login to view comments.
Click here to Login
Stem Cell Transplantation for Newly Diagnosed M/M